There are a few. I will stay in the science theme for one of them, which is changing the way The Congressional Budget Office scores biomedical R and D on a 10-year timeline and relatively conservatively. small C conservatively. They don't take into account a lot of the positive spillovers I think exist changing how the CBO scores. That would have massive leverage improving R and D. (56:13–56:18)
CLAIM
Asserts that the CBO uses a 10-year timeline and conservative estimates for biomedical R&D scoring.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
